ACEA US Cardio Symposium

02 August, 2018
US Cardio Symposium 2018 | Sept 29, 2018

US Cardio Symposium

Ncardia's Greg Luerman (Technical Director) is delighted to be taking part in ACEA's 6th Annual Cardio Symposium on September 29, 2018, in Washington, D.C., held one day prior to the SPS 2018 Annual Meeting. The event will tentatively begin Saturday morning and end in the early evening with a cocktail reception.

Speakers will include;

  • Frederick Sannajust, Ph.D. from Merck, USA
  • Ian Moench, Ph.D. from GlaxoSmithKline, USA
  • Yasunari Kanda, Ph.D. from NIHS, JAPAN
  • Kohei Sawada, Ph.D. from University of Tokyo, JAPAN
  • Farah Sheikh, Ph.D., FCVS, FAHA from UC San Diego, USA
  • Matthew C. White, Ph.D. from Arkansas College of Osteopathic Medicine, USA
  • Greg Luerman, Ph.D. from Ncardia, USA
  • T.K. Feaster, Ph.D. from FUJIFILM Cellular Dynamics, USA

Click Here to Register


Cardiotoxicity and cardiac liability continues to be a major hurdle in drug development. Functional screening of cardiomyocytes demands models which are both clinically relevantand scalable. Human induced pluripotent stem cells (hiPSC) offer this potential and current endeavours are being undertaken by pharmaceutical industry, academic institutions, and regulatory agencies to develop higher throughput and more predictive assays that can be used earlier in the drug discovery/development pipeline to minimize both cost and risk.

ACEA Biosciences’ annual Cardio Symposium is a forum to promote scientific exchange and collaboration amongst scientists working at the forefront of cardiac safety assessment and cardiovascular disease model research. Experts from both industry and academia will share their findings on combining hiPSC cardiomyocytes, cellular impedance, MEA and other technologies for cardiac safety assessment and cardiovascular disease studies.

Register today! Free registration for the first 25 registrants using promo code EarlyCardio18a. All others enjoy 66% OFF through 8/17/2018!